Novel therapy may prove effective in treatment of 30 percent of cancers
A ground-breaking Canada-wide clinical trial led by Dr. Katherine Borden, at the Institute for Research in Immunology and Cancer (IRIC) of the Université de Montréal, has shown that a common anti-viral drug, ribavirin, can be beneficial in the treatment of cancer patients.
Drug That Targets Vasculature Growth Attacks Aggressive Thyroid Cancer
A medication that helps stop the growth of new blood vessels has produced dramatic benefits for some patients with aggressive thyroid cancer, research from Mayo Clinic indicates.
Two Targeted Therapies Likely Better Than One in Patients with Aggressive Lymphoma
When combined with a cocktail of chemotherapy drugs, two monoclonal antibodies, instead of one, appear to offer superior results in patients with diffuse large B-cell lymphoma, according to Mayo Clinic researchers working with the North Central Cancer Treatment Group (NCCTG).
New Technique May Help Detect Potential Breast Cancer Spread
A new phase III clinical trial of early stage breast cancer patients has shown that a molecule designed to home in on nearby lymph nodes is just as accurate as current techniques, but faster, more specific and easier to use.
Iron Induces Death in Tumor Cells
Tumor cells and healthy cells differ considerably in metabolism intensity. Scientist of the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) have taken advantage of this difference: By releasing cellular iron they were able to induce death selectively in tumor cells.
- Fox Chase Surgeon Performs the World's First Successful ViKY® Robot Assisted Surgery to Treat Pancreatic Tumors
- Tales of the 'Trojan horse drug' and the 'miracle dogs'
- The Navel: a Single, Safe Surgical Access Route for Kidney Extraction
- Researchers Identify Potential Therapeutic Target in Osteosarcoma